Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 31 March 2021

Yesterday’s UK 100 Leaders Price (p) % Chg
BARCLAYS PLC 189.1 4.9%


Yesterday’s UK 100 Laggards Price (p) % Chg
FRESNILLO PLC 857.4 -4.1%
OCADO GROUP PLC 2030.0 -2.3%
SEVERN TRENT PLC 2294.0 -2.1%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 6,772 0.5% 19.4%
DOW JONES INDUS. AVG 33,067 -0.3% 48.1%
DAX INDEX 15,009 1.3% 51.1%
NIKKEI 225 29,179 -0.9% 54.3%
S&P/ASX 200 INDEX 6,791 0.8% 33.8%


Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 60.85 0.50%
Brent Crude (ICE) USD/bbl. 64.50 0.56%
Gold Spot USD/t oz. 1,689 0.2%
Copper (Comex) USd/lb. 399 0.3%


UK 100 is called to open -12 points this morning at 6760.

1 Day; 8 Months

Click graph to enlarge

Markets Overview:


UK 100 is called to open -12 points this morning at 6760.  The UK bluechip index is called lower this morning as investor sentiment from weaker global sessions yesterday seems to have filtered through to Europe, as US treasury yields once again rose yesterday.  This let to The Dow Jones ending the session on Tuesday down by 0.31% at close at 33.066 while the S&P dropped similarly 0.32% to end the session at 3,958 and the Nasdaq completed the red day stateside falling by 0.11% to 13,045.  The picture was much the same in Asia this morning, The Hang Seng index in Hong Kong slipped 0.31% while the Shanghai Composite in China fell 0.61%.  In Japan, the Nikkei gave up 0.73%.

Company News & Broker Comments:



Company News:

AstraZeneca: Germany will restrict the use of AstraZeneca’s COVID-19 vaccine to people aged 60 and over and high priority groups.


GKP wings to a 2020 pretax loss of $47m (2019: $43.3m profit) as they are to reinstate their annual dividend totalling $25m in 2021. Their average 2020 output was 36,625 bopd, which beat guidance.


Petropavlovsk increases their guidance for 2021 gold production to 470,000 ounces (from 430,000 ounces) as they plan to complete their management restructure by Q2.


Broker Comments:

Jefferies Upgrades Hikma Pharmaceuticals to a Buy from Hold (4 Buys / 3 Holds / 1 Sell)


Morgan Stanley Downgrades BP to Underweight from Equal weight (6 Buys / 8 Holds / 2 Sells)




Reporting Today:





Reporting Tomorrow:




In Focus Today:


Chinese Non-Manufacturing PMI

Chinese NBS Manufacturing PMI

UK Gross Domestic Product

EU Consumer Price Index – Core

President Biden speech

US ADP Employment Change

German Unemployment Change

US Pending Home Sales



Tomorrow’s Ex Dividends:


UK 100:


Phoenix Group Holdings

Taylor Wimpey

Smith & Nephew

Melrose Industries


UK 250:



Murray International Trust


ConvaTec Group


Primary Health Properties

Chemring Group

Finsbury Growth & Income Trust

RIT Capital Partners



For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.

Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.